What Proteins and Albumins in Bronchoalveolar Lavage Fluid and Serum Could Tell Us in COVID-19 and Influenza Acute Respiratory Distress Syndrome on Mechanical Ventilation Patient - A Prospective Double Center Study

Overview

Journal J Crit Care Med (Targu Mures)

Publisher Sciendo

Specialty Critical Care

Date 2025 Feb 28

PMID 40017475

Authors

Anita Djurdjevic Svraka

Dragan Svraka

Bosa Mrjanic Azaric

Jovana Malic

Goran Baric

Pedja Kovacevic

Affiliations

Soon will be listed here.

Abstract

Introduction: The extent of in vivo damage to the alveolar-capillary membrane in patients with primary lung injury remains unclear. In cases of ARDS related to COVID-19 and Influenza type A, the complexity of the damage increases further, as viral pneumonia cannot currently be treated with a causal approach.

Aims Of The Study: Our primary goal is to enhance the understanding of Acute Respiratory Distress Syndrome (ARDS) by demonstrating damage to the alveocapillary membrane in critically ill patients with COVID-19 and influenza type A. We will achieve this by measuring the levels of proteins and albumin in bronchoalveolar fluid (BAL) and serum. Our secondary objective is to assess patient outcomes related to elevated protein and albumin levels in both BAL and blood serum, which will deepen our understanding of this complex condition.

Materials And Methods: Bronchoalveolar lavage (BAL) fluid and serum samples were meticulously collected from a total of 64 patients, categorized into three distinct groups: 30 patients diagnosed with COVID-19-related acute respiratory distress syndrome (ARDS), 14 patients with influenza type A (H1N1 strain), also experiencing ARDS, and a control group consisting of 20 patients who were preoperatively prepared for elective surgical procedures without any diagnosed lung disease. The careful selection and categorization of patients ensure the robustness of our study. BAL samples were taken within the first 24 hours following the commencement of invasive mechanical ventilation in the intensive care unit, alongside measurements of serum albumin levels. In the control group, BAL and serum samples were collected after the induction of general endotracheal anaesthesia.

Results: Patients in the COVID-19 group are significantly older than those in the Influenza type A (H1N1) group, with median ages of 72.5 years and 62 years, respectively (p < 0.01, Mann-Whitney U test). Furthermore, serum albumin levels (measured in g/L) revealed significant differences across all three groups in the overall sample, yielding a p-value of less than 0.01 according to ANOVA. In terms of treatment outcomes, serum albumin levels also exhibited a significant correlation, with a p-value of 0.03 (Mann-Whitney U test). A reduction in serum albumin levels (below 35 g/L), combined with elevated protein levels in bronchoalveolar lavage (BAL), serves as a predictor of poor outcomes in patients with acute respiratory distress syndrome (ARDS), as indicated by a p-value of less than 0.01 (ANOVA).

Conclusions: Our findings indicate that protein and albumin levels in bronchoalveolar lavage (BAL) fluid are elevated in severe acute respiratory distress syndrome (ARDS) cases. This suggests that BAL can effectively evaluate protein levels and fractions, which could significantly assist in assessing damage to the alveolocapillary membrane. Additionally, the increased albumin levels in BAL, often accompanied by a decrease in serum albumin levels, may serve as a valuable indicator of compromised integrity of the alveolar-capillary membrane in ARDS, with potential implications for patient care.

References

Wang Y, Wang H, Zhang C, Zhang C, Yang H, Gao R . Lung fluid biomarkers for acute respiratory distress syndrome: a systematic review and meta-analysis. Crit Care. 2019; 23(1):43. PMC: 6373030. DOI: 10.1186/s13054-019-2336-6. View

Gattinoni L, Pesenti A . The concept of "baby lung". Intensive Care Med. 2005; 31(6):776-84. DOI: 10.1007/s00134-005-2627-z. View

ASHBAUGH D, Bigelow D, Petty T, LeVine B . Acute respiratory distress in adults. Lancet. 1967; 2(7511):319-23. DOI: 10.1016/s0140-6736(67)90168-7. View

Tiruneh S, Tesema Z, Azanaw M, Angaw D . The effect of age on the incidence of COVID-19 complications: a systematic review and meta-analysis. Syst Rev. 2021; 10(1):80. PMC: 7980104. DOI: 10.1186/s13643-021-01636-2. View

Bain W, Yang H, Shah F, Suber T, Drohan C, Al-Yousif N . COVID-19 versus Non-COVID-19 Acute Respiratory Distress Syndrome: Comparison of Demographics, Physiologic Parameters, Inflammatory Biomarkers, and Clinical Outcomes. Ann Am Thorac Soc. 2021; 18(7):1202-1210. PMC: 8328355. DOI: 10.1513/AnnalsATS.202008-1026OC. View

Kovacevic P, Matijasevic J, Dragic S, Zlojutro B, Gavrilovic S, Jandric M . Characteristics and outcomes of critically ill patients with influenza A (H1N1) in the Western Balkans during the 2019 post-pandemic season. Indian J Med Microbiol. 2020; 38(3 & 4):415-420. DOI: 10.4103/ijmm.IJMM_20_169. View

Hoeboer S, Oudemans-van Straaten H, Groeneveld A . Albumin rather than C-reactive protein may be valuable in predicting and monitoring the severity and course of acute respiratory distress syndrome in critically ill patients with or at risk for the syndrome after new onset fever. BMC Pulm Med. 2015; 15:22. PMC: 4381515. DOI: 10.1186/s12890-015-0015-1. View

Vincent J, Slutsky A . We've never seen a patient with ARDS!. Intensive Care Med. 2020; 46(12):2133-2135. PMC: 7553366. DOI: 10.1007/s00134-020-06255-4. View

Katzenstein A, Bloor C, Leibow A . Diffuse alveolar damage--the role of oxygen, shock, and related factors. A review. Am J Pathol. 1976; 85(1):209-28. PMC: 2032554. View

10.

Ramirez P, Gordon M, Martin-Cerezuela M, Villarreal E, Sancho E, Padros M . Acute respiratory distress syndrome due to COVID-19. Clinical and prognostic features from a medical Critical Care Unit in Valencia, Spain. Med Intensiva (Engl Ed). 2020; 45(1):27-34. PMC: 7833115. DOI: 10.1016/j.medin.2020.06.015. View

11.

Karagiorga G, Nakos G, Galiatsou E, Lekka M . Biochemical parameters of bronchoalveolar lavage fluid in fat embolism. Intensive Care Med. 2005; 32(1):116-23. DOI: 10.1007/s00134-005-2868-x. View

12.

Gebhard C, Regitz-Zagrosek V, Neuhauser H, Morgan R, Klein S . Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ. 2020; 11(1):29. PMC: 7247289. DOI: 10.1186/s13293-020-00304-9. View

13.

Pelosi P, DOnofrio D, Chiumello D, Paolo S, Chiara G, Capelozzi V . Pulmonary and extrapulmonary acute respiratory distress syndrome are different. Eur Respir J Suppl. 2003; 42:48s-56s. DOI: 10.1183/09031936.03.00420803. View

14.

Tomashefski Jr J . Pulmonary pathology of acute respiratory distress syndrome. Clin Chest Med. 2000; 21(3):435-66. DOI: 10.1016/s0272-5231(05)70158-1. View

15.

Mangialardi R, Martin G, Bernard G, Wheeler A, Christman B, Dupont W . Hypoproteinemia predicts acute respiratory distress syndrome development, weight gain, and death in patients with sepsis. Ibuprofen in Sepsis Study Group. Crit Care Med. 2000; 28(9):3137-45. DOI: 10.1097/00003246-200009000-00001. View

16.

Tang X, Du R, Wang R, Cao T, Guan L, Yang C . Comparison of Hospitalized Patients With ARDS Caused by COVID-19 and H1N1. Chest. 2020; 158(1):195-205. PMC: 7151343. DOI: 10.1016/j.chest.2020.03.032. View

17.

Martin T, Rubenfeld G, Ruzinski J, GOODMAN R, Steinberg K, Leturcq D . Relationship between soluble CD14, lipopolysaccharide binding protein, and the alveolar inflammatory response in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med. 1997; 155(3):937-44. DOI: 10.1164/ajrccm.155.3.9117029. View

18.

Rubenfeld G, Caldwell E, Peabody E, Weaver J, Martin D, Neff M . Incidence and outcomes of acute lung injury. N Engl J Med. 2005; 353(16):1685-93. DOI: 10.1056/NEJMoa050333. View

19.

Farjanel J, Hartmann D, Guidet B, Luquel L, Offenstadt G . Four markers of collagen metabolism as possible indicators of disease in the adult respiratory distress syndrome. Am Rev Respir Dis. 1993; 147(5):1091-9. DOI: 10.1164/ajrccm/147.5.1091. View

20.

Nakos G, Pneumatikos J, Tsangaris I, Tellis C, Lekka M . Proteins and phospholipids in BAL from patients with hydrostatic pulmonary edema. Am J Respir Crit Care Med. 1997; 155(3):945-51. DOI: 10.1164/ajrccm.155.3.9117030. View